Subjects - Business

Xhanging a brand name requires a lot of energy. OpenBC, the networking c

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ompany, has taken this mayor step to change their (brand) name. From now

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

on, they are called XING.

Improvement.

The X as the first letter of t

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

he brand seems more than a reasonable choice. Networking is the exchangi

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ng element in productivity. There is no other letter that points that ou

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t. Exactly. It is a short and therefore easy name to remember. Long nam

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

es require practice before you remember them, and there is no time to lo

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

se if you want to change your brand name. It sounds also strong. XING.

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Like a Chinese Giant cooperation. That is my first association with this

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

name.

Change.

There is – as I understand it – no way back. The old na

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

me openBC will leave the stage forever. This means that the new name wil

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

l introduce a new culture.

Culture.

OpenBC, now XING, is much more tha

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

n LinkedIn an international and multicultural organization. The first t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

hings you will observe when you surf to the www.openbc.com homepage are

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

he little flags symbolizing the different cultures.

Acceptance.

To me

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

the new name sounds still a bit strange. I feel that I do not automatic

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ally accept the new name. This probably requires some time. Instead of s

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

eeing XING.COM, my attention is lead to XING.KONG, or King Kong. But g

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ive us some time, I think people will appreciate the name later on.

Tha

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/7848/subjects-XING.html">XING</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/7848/subjects-XING.html]XING[/url]

More than a few people prefer to form corporations to protect their businesses, but look for a more favorable tax situation. The answer, of course, is the S-corporation.

Are You At Risk Being A Broker? The Stages of Import & Export Product Trade Can Be Just As Dangerous As Toying With An Overgrown Anaconda During Meal Time.

Your business brand would resides in your potential customer's mind which come from result of all the impressions that they’ve encountered before hand, which associated with your business name, your business logo, your marketing management messages, and all the other little things that people could possibly see and hear about your business.

Tags

Links

Subjects - XING

Related Articles: